iDose® TR

A sustained-release, drop-free option for long-term eye pressure control

Glaucoma can feel overwhelming, especially when you are juggling multiple drops, side effects, and busy days. The iDose glaucoma implant gives our glaucoma specialists another way to lower pressure steadily, without relying only on your ability to remember bottles and schedules.

What is the iDose® TR Glaucoma Implant?

The iDose® TR travoprost intracameral implant is an FDA-approved, sustained-release device that is placed inside the eye during a brief procedure. Instead of placing travoprost on the surface as a drop, the implant delivers a controlled dose of the same type of medication directly where it works, inside the eye’s drainage system.

At West Texas Eye Associates, our glaucoma specialists use this technology to help patients with open-angle glaucoma or ocular hypertension maintain more stable eye pressure without the constant burden of strict drop schedules.

Play Video
Image sample of a thumb against the iDose TR implant.
iDose TR Banner for West Texas Eye Associates

Who is a Good Candidate at West Texas Eye Associates?

Glaucoma specialist at West Texas Eye Associates discussing the iDose glaucoma implant with an older patient in a modern exam room at West Texas Eye Associates

You may benefit from the iDose glaucoma implant if you:

  • Have open-angle glaucoma or ocular hypertension
  • Struggle with dropping adherence or often forget daily doses
  • Have difficulty with arthritis, tremors, or dexterity that makes dropping use hard
  • Experience redness or irritation from traditional glaucoma drops
  • Prefer a long-acting option that reduces daily tasks
  • Need steadier, more predictable pressure control over time

Our glaucoma specialists will review your optic nerve, eye pressure history, anatomy, and prior treatments to determine whether iDose® TR is the safest and most effective option for your long-term care plan.

How the iDose® TR procedure works

The iDose® TR procedure is minimally invasive and performed in a controlled outpatient setting. Most patients find the process straightforward and comfortable.

Here is what to expect:

  1. Numbing drops are applied, so no needles are needed.
  2. A micro incision is created at the edge of the cornea.
  3. The tiny titanium implant is gently placed into the trabecular meshwork, the eye’s natural drainage channel.
  4. The device begins releasing travoprost continuously over time.

Patients go home soon after the procedure and usually return to normal routines within a day or two. The implant is not visible in the mirror and cannot be felt once it is in place.

Size example of iDose TR to the instrument used during surgery.

Why Patients in West Texas Choose the  iDose® TR Glaucoma Implant

1

Drop freedom and daily convenience

For many people, the hardest part of glaucoma care is not the diagnosis; it is keeping up with drops. The iDose glaucoma implant can help by providing:

  • Relief from eye drop schedules
  • Fewer worries about forgetting doses
  • Less frustration with squeezing small bottles
  • A single long-acting solution that supports pressure stability
2

Fewer ocular surface side effects

Topical drops can cause redness, dryness, burning, and surface irritation, especially after years of use. Because the iDose glaucoma implant delivers medication inside the eye, it bypasses the surface entirely. This may reduce some of the ocular surface side effects that bother patients on traditional therapy.

3

Strong clinical outcomes

Clinical trials of iDose® TR have shown:

  • Significant reductions in intraocular pressure
  • Results that are comparable to, or better than, daily prostaglandin drops for many patients
  • Safe placement and durable performance over time

For patients who are frustrated with drops or worried about long-term adherence, the iDose glaucoma implant offers an evidence-based alternative.

Learn if you are a candidate for the iDose® TR Glaucoma Implant Today

Glaucoma care should support your life, not take it over. If you are tired of juggling drops, side effects, and constant reminders, the iDose glaucoma implant may offer a safer, steadier way to control eye pressure over time.

Schedule Today!

Safety, Side Effects, and What to Expect

Clinical studies show that iDose® TR is generally well tolerated. As with any eye procedure, side effects are possible, but most are temporary and manageable. The most common effects reported in trials, typically in about 2 to 6 percent of patients, included:

  • Mild eye redness or irritation
  • Temporary eye pressure fluctuations
  • Dry eye symptoms
  • Iritis or inflammation
  • Subtle visual field changes

Your surgeon at West Texas Eye Associates will review your overall health, glaucoma status, and other eye conditions, then discuss risks, alternatives, and follow-up plans in detail during your glaucoma consultation.

Middle aged Hispanic carpenter rubbing his eye from discomfort in a wood shop, representing dry eye symptoms before receiving the iDose glaucoma implant with West Texas Eye Associates

How Long Does the iDose® TR Glaucoma Implant Work?

Close up medical illustration showing the iDose glaucoma implant seated in the trabecular meshwork drainage channel inside the eye at west texas eye associates

The iDose® TR device is designed as a long-duration therapy, with pressure-lowering effects expected to last up to three years.

Your personal results depend on factors such as:

  • Your specific glaucoma type
  • Your starting eye pressure
  • The health of your optic nerve
  • Any previous treatments or surgeries

Your provider will help you understand your target eye pressure and what success looks like in your case, then monitor you regularly after implantation.

How the iDose Glaucoma Implant Compares to Other Options

The iDose glaucoma implant sits in the middle of the glaucoma treatment spectrum. It can be combined with, or used alongside, other therapies.

  • Daily drops
    • Very effective when used as prescribed, yet adherence challenges are common in real life.
  • SLT laser
    • A drop sparing treatment that improves fluid drainage. Many patients choose SLT before or after iDose®.
  • Microinvasive glaucoma surgery (MIGS)
    • A surgical option often paired with cataract surgery to reduce pressure by enhancing outflow.
  • Traditional glaucoma surgery
    • Reserved for more advanced or high-risk cases that need major pressure reduction.

The iDose glaucoma implant gives West Texas Eye Associates patients a minimally invasive, sustained-release option when drops alone are not enough, but a larger surgery still feels like too big a step.

Two small aftercare eye drop bottles with red and yellow caps on a dark countertop in a modern eye exam room used after the iDose glaucoma implant at West Texas Eye Associates

FAQ about the iDose Glaucoma Implant

Yes. iDose® TR is FDA approved for adults with open-angle glaucoma or ocular hypertension

Some patients can reduce or even eliminate topical drops after implantation, while others still need a simplified regimen. Your eye pressure response will guide the plan.

Per current FDA labeling, iDose® TR is not reimplanted into an eye that has already received it. Your glaucoma specialist will design a long-term strategy that may include other treatments in the future.

No. The device is microscopic and is not felt or seen once it is in place.

Most patients report only mild pressure or awareness during the procedure because numbing drops are used to keep the eye comfortable.

Older Hispanic woman smiling outdoors with clear vision after receiving the iDose glaucoma implant at West Texas Eye Associates

Ready to See if the iDose® TR Glaucoma Implant is Right for You?

Schedule an evaluation at West Texas Eye Associates to talk with a glaucoma specialist about whether the iDose glaucoma implant belongs in your treatment plan.

Schedule Today!